| mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
| mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |